WUHN Stock Price, Chart, Stats & News

Wuhan General Group (China), Inc.
Save
Wuhan General Group (China), Inc. (WUHN) does not currently pay a dividend.
16,545
Market cap
–
Current P/E
–
Forward P/E
WUHN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's.
Similar securities
Based on sector and market capitalization
Report issue





